One of the attempts to amplify immunological response in cancers is by activation of the cytosolic DNA sensor, cyclic-GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) pathway, which acts to detect cytosolic DNA and ultimately trigger an innate immune response by producing type I interferons (IFNs). Here, STING1 is linked to cancer.